Business Description
Hyundai Bioland Co Ltd
ISIN : KR7052260007
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.61 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | 1.91 | |||||
Interest Coverage | 7.45 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 3.47 | |||||
Beneish M-Score | -2.34 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.6 | |||||
3-Year Book Growth Rate | -0.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.95 | |||||
9-Day RSI | 36.7 | |||||
14-Day RSI | 38.51 | |||||
6-1 Month Momentum % | -13.42 | |||||
12-1 Month Momentum % | -11.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.93 | |||||
Quick Ratio | 0.9 | |||||
Cash Ratio | 0.44 | |||||
Days Inventory | 211.88 | |||||
Days Sales Outstanding | 52.33 | |||||
Days Payable | 22.38 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.87 | |||||
Dividend Payout Ratio | 0.21 | |||||
3-Year Dividend Growth Rate | -11.2 | |||||
5-Year Yield-on-Cost % | 0.15 | |||||
Shareholder Yield % | 1.32 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 39.85 | |||||
Operating Margin % | 9.49 | |||||
Net Margin % | 6.4 | |||||
FCF Margin % | -1.55 | |||||
ROE % | 5.54 | |||||
ROA % | 4.14 | |||||
ROIC % | 5.71 | |||||
ROC (Joel Greenblatt) % | 8.84 | |||||
ROCE % | 7.9 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 26.61 | |||||
PE Ratio without NRI | 23.77 | |||||
PS Ratio | 1.25 | |||||
PB Ratio | 0.84 | |||||
Price-to-Tangible-Book | 0.91 | |||||
Price-to-Operating-Cash-Flow | 130.07 | |||||
EV-to-EBIT | 12.06 | |||||
EV-to-EBITDA | 7.59 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-FCF | -71.44 | |||||
Price-to-Projected-FCF | 0.86 | |||||
Price-to-Median-PS-Value | 0.44 | |||||
Price-to-Graham-Number | 0.98 | |||||
Price-to-Net-Current-Asset-Value | 2.88 | |||||
Earnings Yield (Greenblatt) % | 8.29 | |||||
FCF Yield % | -1.55 | |||||
Forward Rate of Return (Yacktman) % | -0.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hyundai Bioland Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 121,167.614 | ||
EPS (TTM) (â‚©) | 152 | ||
Beta | 0.81 | ||
Volatility % | 46.94 | ||
14-Day RSI | 38.51 | ||
14-Day ATR (â‚©) | 154.288879 | ||
20-Day SMA (â‚©) | 4200.25 | ||
12-1 Month Momentum % | -11.57 | ||
52-Week Range (â‚©) | 3865 - 7900 | ||
Shares Outstanding (Mil) | 30 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hyundai Bioland Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hyundai Bioland Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Hyundai Bioland Co Ltd Frequently Asked Questions
What is Hyundai Bioland Co Ltd(XKRX:052260)'s stock price today?
When is next earnings date of Hyundai Bioland Co Ltd(XKRX:052260)?
Does Hyundai Bioland Co Ltd(XKRX:052260) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |